JW (Cayman) Therapeutics Co. Ltd
2126.HK
Price:
$2.82
Market Cap:
$1.04B
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for th...[Read more]
Industry
Biotechnology
IPO Date
2020-11-03
Stock Exchange
HKSE
Ticker
2126.HK
PE Ratio
[-1.81]
ROE
[-44.56%]
Current Ratio
[1.74]
Dividend Yield
[0%]
Enterprise Value
[708.47M]
Dividend History
The ROE as of July 2025 (TTM) for JW (Cayman) Therapeutics Co. Ltd (2126.HK) is -44.56%
According to JW (Cayman) Therapeutics Co. Ltd’s latest financial reports and current stock price. The company's current ROE is -44.56%. This represents a change of 108.04% compared to the average of -21.42% of the last 4 quarters.
JW (Cayman) Therapeutics Co. Ltd (2126.HK) Historical ROE (quarterly & annually)
How has 2126.HK ROE performed in the past?
The mean historical ROE of JW (Cayman) Therapeutics Co. Ltd over the last ten years is -7.36%. The current -44.56% ROE has changed 505.62% with respect to the historical average. Over the past ten years (40 quarters), 2126.HK's ROE was at its highest in in the June 2020 quarter at 64.14%. The ROE was at its lowest in in the December 2024 quarter at -29.97%.
Average
-7.36%
Median
-35.94%
Minimum
-50.52%
Maximum
87.04%
JW (Cayman) Therapeutics Co. Ltd (2126.HK) ROE by Quarter and Year
Discovering the peaks and valleys of JW (Cayman) Therapeutics Co. Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 42.82%
Maximum Annual ROE = 87.04%
Minimum Annual Increase = -172.19%
Minimum Annual ROE = -50.52%
| Year | ROE | Change |
|---|---|---|
| 2024 | -50.52% | 10.76% |
| 2023 | -45.61% | 26.90% |
| 2022 | -35.94% | 42.82% |
| 2021 | -25.17% | -48.12% |
| 2020 | -48.51% | -172.19% |
| 2019 | 67.20% | -22.80% |
JW (Cayman) Therapeutics Co. Ltd (2126.HK) Average ROE
How has 2126.HK ROE performed in the past?
The current ROE of JW (Cayman) Therapeutics Co. Ltd (2126.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-44.02%
5-year avg
-41.15%
10-year avg
-7.36%
JW (Cayman) Therapeutics Co. Ltd (2126.HK) ROE vs. Peers
How is 2126.HK’s ROE compared to its peers?
JW (Cayman) Therapeutics Co. Ltd’s ROE is greater than Yidu Tech Inc. (-4.09%), greater than Innovent Biologics, Inc. (-0.74%), less than WuXi AppTec Co., Ltd. (19.37%), less than HBM Holdings Limited (2.24%), greater than Brii Biosciences Limited (-18.42%),
| Company | ROE | Market cap |
|---|---|---|
| -4.09% | $6.09B | |
| -0.74% | $133.04B | |
| 19.37% | $237.29B | |
| 2.24% | $6.55B | |
| -18.42% | $1.33B |
Build a custom stock screener for JW (Cayman) Therapeutics Co. Ltd (2126.HK) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like JW (Cayman) Therapeutics Co. Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
JW (Cayman) Therapeutics Co. Ltd (2126.HK) and other stocks custom spreadsheet templates
The easiest way to analyze a company like JW (Cayman) Therapeutics Co. Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is JW (Cayman) Therapeutics Co. Ltd's ROE?
How is the ROE calculated for JW (Cayman) Therapeutics Co. Ltd (2126.HK)?
What is the highest ROE for JW (Cayman) Therapeutics Co. Ltd (2126.HK)?
What is the 3-year average ROE for JW (Cayman) Therapeutics Co. Ltd (2126.HK)?
What is the 5-year average ROE for JW (Cayman) Therapeutics Co. Ltd (2126.HK)?
How does the current ROE for JW (Cayman) Therapeutics Co. Ltd (2126.HK) compare to its historical average?